Salacia oblonga has a long history of use in the traditional Ayurvedic medicine system of India. Its bark has been used for treating diabetes, diarrhea, fever, arthritis, gonorrhea and skin diseases.
S. oblonga may work similarly to the standard diabetes drug Acarbose, used in type 2 diabetes. Acarbose inhibits the intestinal enzyme alpha-glucosidase, an enzyme responsible for helping to digest carbohydrates. When alpha-glucosidase is inhibited, carbohydrate absorption is slowed, thereby reducing the rise in blood sugar that follows a meal.
double-blind, placebo controlled studyS. oblonga
However, neither of these studies involved people with diabetes. Further research will be necessary to actually determine whether S. oblonga is a useful treatment for people with this this condition.
S. oblonga has been marketed for preventing type 2 diabetes, as well as for aiding in weight loss . However, there is as yet no evidence whatsoever that it offers either of these benefits.
A typical dose of S. oblonga is 2.5 to 5.0 grams daily of the whole herb, or a comparable amount as extract. The root bark is the part of the plant used.
Maximum safe dosages are not known for pregnant or nursing women, or people with severe liver or kidney disease.
- Reviewer: EBSCO CAM Review Board
- Review Date: 09/2014 -
- Update Date: 09/18/2014 -